Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.
Dangas GD, Lefèvre T, Kupatt C, Tchetche D, Schäfer U, Dumonteil N, Webb JG, Colombo A, Windecker S, Ten Berg JM, Hildick-Smith D, Mehran R, Boekstegers P, Linke A, Tron C, Van Belle E, Asgar AW, Fach A, Jeger R, Sardella G, Hink HU, Husser O, Grube E, Deliargyris EN, Lechthaler I, Bernstein D, Wijngaard P, Anthopoulos P, Hengstenberg C; BRAVO-3 Investigators. Dangas GD, et al. Among authors: webb jg. J Am Coll Cardiol. 2015 Dec 29;66(25):2860-2868. doi: 10.1016/j.jacc.2015.10.003. Epub 2015 Oct 15. J Am Coll Cardiol. 2015. PMID: 26477635 Free article. Clinical Trial.
Coronary stenting for acute myocardial infarction.
Ahmad T, Webb JG, Carere RR, Dodek A. Ahmad T, et al. Among authors: webb jg. Am J Cardiol. 1995 Jul 1;76(1):77-80. doi: 10.1016/s0002-9149(99)80807-8. Am J Cardiol. 1995. PMID: 7793411
Usefulness of coronary stenting for cardiogenic shock.
Webb JG, Carere RG, Hilton JD, Rabinowitz A, Buller E, Dodek AA, Abel J. Webb JG, et al. Am J Cardiol. 1997 Jan 1;79(1):81-4. doi: 10.1016/s0002-9149(96)00683-2. Am J Cardiol. 1997. PMID: 9024744
Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
Webb JG, Sleeper LA, Buller CE, Boland J, Palazzo A, Buller E, White HD, Hochman JS. Webb JG, et al. J Am Coll Cardiol. 2000 Sep;36(3 Suppl A):1084-90. doi: 10.1016/s0735-1097(00)00876-7. J Am Coll Cardiol. 2000. PMID: 10985709 Free article. Clinical Trial.
Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK?
Thompson CR, Buller CE, Sleeper LA, Antonelli TA, Webb JG, Jaber WA, Abel JG, Hochman JS. Thompson CR, et al. Among authors: webb jg. J Am Coll Cardiol. 2000 Sep;36(3 Suppl A):1104-9. doi: 10.1016/s0735-1097(00)00846-9. J Am Coll Cardiol. 2000. PMID: 10985712 Free article. Clinical Trial.
Percutaneous aortic valve implantation: a case report.
Chandavimol M, McClure SJ, Carere RG, Thompson CR, Ricci DR, Mackay MH, Webb JG. Chandavimol M, et al. Among authors: webb jg. Can J Cardiol. 2006 Nov;22(13):1159-61. doi: 10.1016/s0828-282x(06)70954-0. Can J Cardiol. 2006. PMID: 17102835 Free PMC article.
Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial).
Brodie BR, Webb J, Cox DA, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Dulas D, Rutherford B, Antoniucci D, Stuckey T, Krucoff M, Gibbons R, Lansky A, Na Y, Mehran R, Stone GW; EMERALD Investigators. Brodie BR, et al. Am J Cardiol. 2007 Jun 15;99(12):1680-6. doi: 10.1016/j.amjcard.2007.01.047. Epub 2007 May 7. Am J Cardiol. 2007. PMID: 17560875 Clinical Trial.
721 results